Semaglutide May Improve Disordered Eating Symptoms in Adults Treating Obesity
A 60-week trial found that semaglutide significantly reduced loss-of-control eating and improved body image concerns compared with placebo in adults ...
A 60-week trial found that semaglutide significantly reduced loss-of-control eating and improved body image concerns compared with placebo in adults ...
A comprehensive validation study demonstrates that the patient-level Obesity Lifecycle Model reliably predicts long-term cardiovascular outcomes, diabetes incidence, and health ...
European liver, diabetes, and obesity societies have issued joint guidance establishing a noninvasive, phenotype-guided framework for prescribing resmetirom and semaglutide ...
Recent rodent studies demonstrate that phosphodiesterase 4 controls central pathways governing thermogenesis and appetite, offering mechanistic insights for managing concurrent ...
A study in obese mice shows semaglutide reduces body weight without impairing skeletal muscle contractility while improving endurance running performance.
Although GLP-1 receptor agonists produce substantial weight loss in adults taking antipsychotics, a narrative review emphasizes that pediatric trials for ...
A comprehensive review finds that ocular safety signals linked to GLP-1 receptor agonists primarily reflect rapid glycemic shifts in susceptible ...
A modeling study suggests weight loss medications reduce daily energy intake by up to 26 percent initially, altering overall food ...
A scoping review of 12 randomized controlled trials found that semaglutide clinical trials lack direct evidence on oral and dental ...
Daily semaglutide administration in healthy mice altered stress and reward pursuit behaviours while acute exposure shifted nucleus accumbens oscillatory frequencies.
A review shows incretin-based therapies maintain weight-loss efficacy in older adults while highlighting evidence gaps for those over seventy-five.
A narrative review in Frontiers in Endocrinology examines evidence for a brain-gut-bone axis regulating skeletal remodeling and evaluates the hypothesis ...
A retrospective study of 29 patients found that ocular inflammatory disease remained largely stable and well-tolerated following GLP-1 receptor agonist ...
A study in adults with neurodevelopmental obesity found that semaglutide improved appetite regulation and body weight in general neurodevelopmental conditions ...
A narrative review finds GLP-1 receptor agonists consistently attenuate inflammation and preserve organ function in preclinical infection models without acting ...
A narrative review examines how combining GLP-1 receptor agonists with follicle-stimulating hormone could address impaired spermatogenesis in obese men with ...
A target trial emulation evaluating electronic health records from over 20,000 patients found that metabolic surgery and specific medication switches ...
A cross-sectional study reveals significant GLP-1 use among eating disorder patients as emerging non-prescribed peptide markets introduce unassessed injection risks ...
A meta-analysis of ten studies suggests GLP-1 receptor agonists and SGLT-2 inhibitors reduce major adverse cardiovascular events in patients with ...
A review in Science evaluates how obesity and diabetes drugs influence brain function and whether they could help preserve cognitive ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.